Literature DB >> 16691488

The remarkable transport mechanism of P-glycoprotein: a multidrug transporter.

Marwan K Al-Shawi1, Hiroshi Omote.   

Abstract

Human P-glycoprotein (ABCB1) is a primary multidrug transporter located in plasma membranes, that utilizes the energy of ATP hydrolysis to pump toxic xenobiotics out of cells. P-glycoprotein employs a most unusual molecular mechanism to perform this drug transport function. Here we review our work to elucidate the molecular mechanism of drug transport by P-glycoprotein. High level heterologous expression of human P-glycoprotein, in the yeast Saccharomyces cerevisiae, has facilitated biophysical studies in purified proteoliposome preparations. Development of novel spin-labeled transport substrates has allowed for quantitative and rigorous measurements of drug transport in real time by EPR spectroscopy. We have developed a new drug transport model of P-glycoprotein from the results of mutagenic, quantitative thermodynamic and kinetic studies. This model satisfactorily accounts for most of the unusual kinetic, coupling, and physiological features of P-glycoprotein. Additionally, an atomic detail structural model of P-glycoprotein has been devised to place our results within a proper structural context.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16691488      PMCID: PMC1459968          DOI: 10.1007/s10863-005-9497-5

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  58 in total

1.  Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport.

Authors:  S C Hyde; P Emsley; M J Hartshorn; M M Mimmack; U Gileadi; S R Pearce; M P Gallagher; D R Gill; R E Hubbard; C F Higgins
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

2.  Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.

Authors:  K Yusa; T Tsuruo
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

3.  Hydrophobic ion interactions with membranes. Thermodynamic analysis of tetraphenylphosphonium binding to vesicles.

Authors:  R F Flewelling; W L Hubbell
Journal:  Biophys J       Date:  1986-02       Impact factor: 4.033

Review 4.  Conformation of polypeptides and proteins.

Authors:  G N Ramachandran; V Sasisekharan
Journal:  Adv Protein Chem       Date:  1968

5.  P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance.

Authors:  N Kioka; J Tsubota; Y Kakehi; T Komano; M M Gottesman; I Pastan; K Ueda
Journal:  Biochem Biophys Res Commun       Date:  1989-07-14       Impact factor: 3.575

6.  Disulfide cross-linking analysis shows that transmembrane segments 5 and 8 of human P-glycoprotein are close together on the cytoplasmic side of the membrane.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

Review 7.  ATP-binding cassette transporters in bacteria.

Authors:  Amy L Davidson; Jue Chen
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

8.  Val133 and Cys137 in transmembrane segment 2 are close to Arg935 and Gly939 in transmembrane segment 11 of human P-glycoprotein.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2004-01-28       Impact factor: 5.157

9.  An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.

Authors:  K H Choi; C J Chen; M Kriegler; I B Roninson
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

10.  Improved energy coupling of human P-glycoprotein by the glycine 185 to valine mutation.

Authors:  Hiroshi Omote; Robert A Figler; Mark K Polar; Marwan K Al-Shawi
Journal:  Biochemistry       Date:  2004-04-06       Impact factor: 3.162

View more
  24 in total

1.  P-glycoprotein retains drug-stimulated ATPase activity upon covalent linkage of the two nucleotide binding domains at their C-terminal ends.

Authors:  Brandy Verhalen; Stephan Wilkens
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

2.  P-glycoprotein-ATPase modulation: the molecular mechanisms.

Authors:  Xiaochun Li-Blatter; Andreas Beck; Anna Seelig
Journal:  Biophys J       Date:  2012-03-20       Impact factor: 4.033

3.  Molecular dissection of dual pseudosymmetric solute translocation pathways in human P-glycoprotein.

Authors:  Zahida Parveen; Thomas Stockner; Caterina Bentele; Sandra Pferschy; Martin Kraupp; Michael Freissmuth; Gerhard F Ecker; Peter Chiba
Journal:  Mol Pharmacol       Date:  2010-12-21       Impact factor: 4.436

4.  Conformational coupling of the nucleotide-binding and the transmembrane domains in ABC transporters.

Authors:  Po-Chao Wen; Emad Tajkhorshid
Journal:  Biophys J       Date:  2011-08-03       Impact factor: 4.033

5.  Proposed mechanistic description of dose-dependent BDE-47 urinary elimination in mice using a physiologically based pharmacokinetic model.

Authors:  Claude Emond; J Michael Sanders; Daniele Wikoff; Linda S Birnbaum
Journal:  Toxicol Appl Pharmacol       Date:  2013-09-19       Impact factor: 4.219

Review 6.  Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment.

Authors:  Deepali Waghray; Qinghai Zhang
Journal:  J Med Chem       Date:  2017-12-28       Impact factor: 7.446

7.  A Conformationally Gated Model of Methadone and Loperamide Transport by P-Glycoprotein.

Authors:  Morgan E Gibbs; Laura A Wilt; Kaitlyn V Ledwitch; Arthur G Roberts
Journal:  J Pharm Sci       Date:  2018-02-28       Impact factor: 3.534

8.  A mutation of the H-loop selectively affects rhodamine transport by the yeast multidrug ABC transporter Pdr5.

Authors:  Robert Ernst; Petra Kueppers; Cornelia M Klein; Tobias Schwarzmueller; Karl Kuchler; Lutz Schmitt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-20       Impact factor: 11.205

Review 9.  BDDCS, the Rule of 5 and drugability.

Authors:  Leslie Z Benet; Chelsea M Hosey; Oleg Ursu; Tudor I Oprea
Journal:  Adv Drug Deliv Rev       Date:  2016-05-13       Impact factor: 15.470

Review 10.  Structure, function, and evolution of bacterial ATP-binding cassette systems.

Authors:  Amy L Davidson; Elie Dassa; Cedric Orelle; Jue Chen
Journal:  Microbiol Mol Biol Rev       Date:  2008-06       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.